Your browser doesn't support javascript.
loading
Neurocognition and adaptive functioning in a genetic high risk model of schizophrenia.
Fiksinski, A M; Breetvelt, E J; Lee, Y J; Boot, E; Butcher, N; Palmer, L; Chow, E W C; Kahn, R S; Vorstman, J A S; Bassett, A S.
Afiliação
  • Fiksinski AM; Department of Psychiatry,Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht,Utrecht,The Netherlands.
  • Breetvelt EJ; Clinical Genetics Research Program, Centre for Addiction and Mental Health,Toronto, Ontario,Canada.
  • Lee YJ; Clinical Genetics Research Program, Centre for Addiction and Mental Health,Toronto, Ontario,Canada.
  • Boot E; Clinical Genetics Research Program, Centre for Addiction and Mental Health,Toronto, Ontario,Canada.
  • Butcher N; Clinical Genetics Research Program, Centre for Addiction and Mental Health,Toronto, Ontario,Canada.
  • Palmer L; The Dalglish Family 22q Clinic for 22q11.2 Deletion Syndrome,Toronto General Hospital,University Health Network,Toronto, Ontario,Canada.
  • Chow EWC; Clinical Genetics Research Program, Centre for Addiction and Mental Health,Toronto, Ontario,Canada.
  • Kahn RS; Department of Psychiatry,Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht,Utrecht,The Netherlands.
  • Vorstman JAS; Department of Psychiatry,Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht,Utrecht,The Netherlands.
  • Bassett AS; Clinical Genetics Research Program, Centre for Addiction and Mental Health,Toronto, Ontario,Canada.
Psychol Med ; 49(6): 1047-1054, 2019 04.
Article em En | MEDLINE | ID: mdl-30064532
ABSTRACT

BACKGROUND:

Identifying factors that influence the functional outcome is an important goal in schizophrenia research. The 22q11.2 deletion syndrome (22q11DS) is a unique genetic model with high risk (20-25%) for schizophrenia. This study aimed to identify potentially targetable domains of neurocognitive functioning associated with functional outcome in adults with 22q11DS.

METHODS:

We used comprehensive neurocognitive test data available for 99 adults with 22q11DS (n = 43 with schizophrenia) and principal component analysis to derive four domains of neurocognition (Verbal Memory, Visual and Logical Memory, Motor Performance, and Executive Performance). We then investigated the association of these neurocognitive domains with adaptive functioning using Vineland Adaptive Behavior Scales data and a linear regression model that accounted for the effects of schizophrenia status and overall intellectual level.

RESULTS:

The regression model explained 46.8% of the variance in functional outcome (p < 0.0001). Executive Performance was significantly associated with functional outcome (p = 0.048). Age and schizophrenia were also significant factors. The effects of Executive Performance on functioning did not significantly differ between those with and without psychotic illness.

CONCLUSION:

The findings provide the impetus for further studies to examine the potential of directed (early) interventions targeting Executive Performance to improve long-term adaptive functional outcome in individuals with, or at high risk for, schizophrenia. Moreover, the neurocognitive test profiles may benefit caregivers and clinicians by providing insight into the relative strengths and weaknesses of individuals with 22q11DS, with and without psychotic illness.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Psicologia do Esquizofrênico / Adaptação Psicológica / Cognição Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Psychol Med Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Psicologia do Esquizofrênico / Adaptação Psicológica / Cognição Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Psychol Med Ano de publicação: 2019 Tipo de documento: Article